Opioid diketopiperazines: Synthesis and activity of a prototypic class of opioid antagonists

Biological Chemistry

Volumn 378, Issue 1, 1997, Pages 19-29

  Balboni, Gianfranco ^a   Guerrini, Remo ^a   Salvadori, Severo ^a   Tomatis, Roberto ^a   Bryant, Sharon D ^b   Bianchi, Clementina ^a   Attila, Martti ^c   Lazarus, Lawrence H ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Antagonist; Diketopiperazine; Opioid peptides; Peptide synthesis

Indexed keywords

AROMATIC COMPOUND; CARBOXYLIC ACID DERIVATIVE; HYDROXYL GROUP; METHYL GROUP; OPIATE; OPIATE ANTAGONIST; OPIATE PEPTIDE; PIPERAZINEDIONE; SIGMA OPIATE RECEPTOR; TETRAHYDROISOQUINOLINE DERIVATIVE; TYROSINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; DIASTEREOISOMER; HYDROGEN BOND; HYDROPHOBICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SYNTHESIS; VAS DEFERENS;

ANIMALIA;

EID: 0031045077     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/bchm.1997.378.1.19     Document Type: Article

References (86)

1. Adamczeski, M., Reed, A.R., and Crews, P. (1995). New and known diketopiperazines from the Caribbean sponge, Calyx cf. podatypa. J. Nat. Products 58, 201-208.
2. Arunlakshansa, O., and Schild, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14, 48-58.
3. Attila, M., Salvadori, S., Balboni, G., Bryant, S.D., and Lazarus, L.H. (1993). Synthesis and receptor binding analysis of dermorphin hepta-, hexa-and pentapeptide analogues. Int. J. Peptide Prot. Res. 42, 550-559.
4. Banks, W.A., Kastin, A.J., Akerstromy, and Jaspan, J.B. (1993). Radioactive iodinated cyclo(His-Pro) crosses the blood brain barrier and reverses ethanol-induced narcosis. Amer. J. Physiol. 264, E 723-E 729.
5. Battersby, J.E., Hancock, W.S., Canova-Davis, E., Oeswein, J., and O'Connor, B. (1994). Diketopiperazine formation and N-terminal degradation in recombinant human growth hormone. Int. J. Pept. Prot. Res. 44, 215-222.
6. Befort, K., Tabbara, L., Bausch, S., Chavkin, C., Evans, C., and Kieffer, B. (1996a). The conserved aspartate residue in the third putative transmembrane domain of the δ-opioid receptor is not the anionic counterpart for cationic opiate binding but is a constituent of the receptor binding site. Mol. Pharmacol. 49, 216-223.
7. Befort, K., Tabbara, L., Kling, D., Maigret, B., and Kieffer, B. (1996b). Role of aromatic transmembrane residues of the δ-opioid receptor in ligand recognition. J. Biol. Chem. 271, 10161-10168.
8. Bhargava, H.N. (1980). The effects of thyrotropin releasing hormone and histidyl-proline diketopiperazine on delta-9-tetrahydrocannabinol-induced hypothermia. Life Sci. 26, 845-850.
9. Brandt, W., Barth, A., and Höltje, H.-D. (1993). A new consistent model explaining structure (conformation)-activity relationship of opiates with μ-selectivity. Drug Design Disc. 10, 257-283.
10. 3 residue to different domains of the opioid receptors. J. Computer-Aided Mol. Des. 10, 201-212.
11. Breveglieri, A., Guerrini, R., Salvadori, S., Bianchi, C., Bryant, S.D., Attila, M., and Lazarus, L.H. (1996). Design and synthesis of 1-aminocycloalkane-1-carboxylic acid-substituted deltorphin analogues: unique δ and μ opioid activity in modified peptides. J. Med. Chem. 39, 773-780.
12. Bryant, S.D., Attila, M., Salvadori, S., Guerrini, R., and Lazarus, L.H. (1994). Molecular dynamics conformations of deltorphin analogues advocate δ opioid binding site models. Peptide Res. 7, 175-184.
13. Capasso, A., Guerrini, R., Balboni, G., Sorrentino, L., Temussi, P.A., Lazarus, L.H., Bryant, S.D., and Salvadori, S. (1996). Dmt-Tic-OH, a highly selective and potent δ opioidmimetic receptor antagonist after systemic administration in the mouse. Life Sci. 59, PL 93-PL 98.
14. Capasso, S., Sica, F., Mazzarella, L., Balboni, G., Guerrini, R., and Salvadori, S. (1995). Acid catalysis in the formation of dioxo-piperazines from peptides containing tetrahydroisoquinoline-3-carboxylic acid at position 2. Int. J. Pept. Prot. Res. 45, 567-573.
15. Carlton, J., Khan, S.I., Haq, W., Mizuma, H., Ragan, F.A., Jr., Mathur, K.B., Shukla, R., Srimal, R.C., and Prasad, C. (1995). Attenuation of alcohol-induced hypothermia by cyclo(His-Pro) and its analogue. Neuropeptides 28, 351-355.
16. Chandrakumar, N.S., Yonan, P.K., Stapelfeld, A., Savage, M., Rorbacher, E., Contreras, P.C., and Hammond, D. (1992). Preparation and opioid activity of analogues of the analgesic dipeptide2,6-dimethyl-L-tyrosyl-N-(3-phenylpropyl)-D-alanin-amide. J. Med. Chem. 35, 223-233.
17. Chen, Y., Fan, Y., Mestek, A., Tian, M., Kozak, C.A., and Yu, L. (1994). Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett. 347, 279-283.
18. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
19. Crush, K.G. (1970). Carnosine and related substances in animal tissues. Comp. Biochem. Physiol. 34, 3-30.
20. Daly, J.W., and Heatwole, H. (1966). Occurrence of carnosine in skin of certain leptodactylid frogs. Experientia 22, 764-765.
21. Dougherty, D.A. (1996). Cation-π interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp. Science 271, 163-168.
22. Dygos, J.H., Yonan, E.E., Scaros, M.G., Goodmonson, O.J., Getman, D.P., Periana, R.A., and Beck, G.R. (1992). A convenient asymmetric synthesis of the unnatural amino acid 2,6-dimethyl-L-tyrosine. Synthesis 8, 741-743.
23. Evans, C.J., Keith, D.E., Jr., Morrison, H., Magendzo, K., and Edwards, R.H. (1992). Cloning of a delta opioid receptor by functional expression. Science 258, 1952-1955.
24. Fukuda, K., Kato, S., Mori, K., Nishi, M., and Takeshima, H. (1993). Primary structures and expression from cDNAs of rat opioid receptor δ-and μ-subtypes. FEBS Lett. 327, 311-314.
25. Fukuda, K., Terasko, K., Kato, S., and Mori, K. (1995). Identification of the amino acid residues involved in selective agonist binding in the first extracellular loop of the δ-and μ-opioid receptors. FEBS Lett. 373, 171-181.
26. Gerig, J.T., and McLeod, R.S. (1976). Attempted synthesis of 2-methylalanyl-L-prolyl-L-tryptophan. An unexpected result. J. Org. Chem. 41, 1653-1655.
27. 1]deltorphin B. Eur. J. Pharmacol. 302, 37-42.
28. 5]enkephalin. J. Med. Chem. 35, 684-687.
29. 3 aromatic ring in cyclic δ opioid receptor-selective dermorphin/ deltorphin tetrapeptide analogues: electronic and lipophilic requirements for receptor affinity. J. Med. Chem. 35, 1535-1541.
30. 3 replacement with ring-substituted and heterocyclic amino acids. J. Med. Chem. 38, 1242-1246.
31. 3 residue in the δ-selective opioid peptide deltorphin I: effects on binding affinity and selectivity. Int. J. Pept. Prot. Res. 44, 420-426.
32. Hilton, C.W., Prasad, C., Vo, P., and Moulton, C. (1992). Food contains the bioactive peptide, cyclo(His-Pro). J. Clin. Endocrinol. Metab. 75, 375-378.
33. Hruby, V.J., and Gehrig, C. (1989). Recent developments in the design of receptor specific opioid peptides. Med. Res. Rev. 9, 343-401.
34. Jikihara, H., Ikegami, H., Koike, K., Wada, K., Morishige, I., Kurachi, H., Hirota, K., Miyake, A., and Tanizawa, O. (1993). Intraventricular administration of histidyl-proline-diketopiperazine [cyclo(His-Pro)] suppresses prolactin secretion and synthesis: a possible role of cyclo(His-Pro) as dopamine uptake blocker in rat hypothalamus. Endocrinol. 132, 953-958.
35. Kaakkola, S., and Wurtman, R.J. (1993). Effects of two diketopiperazines, cyclo(His-Pro) and cyclo(Asp-Pro), on striatal dopamine: a microdialysis study. Brain Res. Bull. 32, 667-672.
36. Kieffer, B.L., Befort, K., Gaveriaux-Ruff, C., and Hirth, G.C. (1992). The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. 89, 12048-12052.
37. Kong, H., Raynor, K., Yasuda, K., Moe, S.T., Portoghese, P.S., Bell, G.I., and Reisine, T. (1993). A single reside, aspartic acid 95, in the δ opioid receptor specifies selective high affinity agonist binding. J. Biol. Chem. 266, 23055-23055.
38. Kosterlitz, H.W., and Watt, A.J. (1968). Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone). Br. J. Pharmacol. Chemother. 33, 266-276.
39. 2-agonist antinociception. Neuro-report 5, 1049-1052.
40. Lazarus, L.H., Wilson, W.E., Guglietta, A., and de Castiglione, R. (1990). Demorphin interaction with rat opioid receptors: involvement of hydrophobic sites in the binding domain. Mol. Pharmacol. 37, 886-892.
41. Lazarus, L.H., SalvadorI, S., Santagada, V., Tomatis, R., and Wilson, W.E. (1991). Function of negative charge in the "address domain" of deltorphins. J. Med. Chem. 34, 1350-1359.
42. Lazarus, L.H., Salvadori, S., Balboni, G., Tomatis, R., and Wilson, W.E. (1992). Stereospecificity of amino acid side chains in deltorphin defines binding to opioid receptors. J. Med. Chem. 35, 1222-1227.
43. Lazarus, L.H., Salvadori, S., Attila, M., Grieco, P., Bundy, D.M., Wilson, W.E., and Tomatis, R. (1993). Interaction of deltorphin with opioid receptors: molecular determinants for affinity and selectivity. Peptides 14, 21-28.
44. Lazarus, L.H., Bryant, S.D., Salvadori, S., Attila, M., and Jones, L.S. (1996). Opioid infidelity: novel opioid peptides with dual high affinity for δ-and μ-receptors. Trends Neurosci. 19, 31-35.
45. Margolis, F.L. (1978). Carnosine. Trends. Neurosci. 1, 42-44.
46. Margolis, F.L., and Grillo, M. (1984). Carnosine, homocarnosine and anserine in vertebrate retinas. Neurochem. Int. 6, 207-209.
47. Marsden, B.J., Nguyen, T.M.-D., and Schiller, P.W. (1993). Spontaneous degradation via diketopiperazine formation of peptides containing a tetrahydroisoquinoline-3-carboxylic acid residue in the 2-position of the peptide sequence. Int. J. Pept. Prot. Res. 41, 313-316.
48. Mazur, R.H., and Schlatter, J.M. (1963). A novel peptide cleavage reaction. J. Org. Chem. 28, 1025-1029.
49. Mazurov, A., Andronati, S.A., Korotenko, T.I., Gorbatyuk, V.Y., and Shapiro, Y.E. (1993). Formation of pyroglutamylglutamine (or asparagine) diketopiperazine in 'non-classical' conditions: a side reaction in peptide synthesis. Int. J. Pept. Prot. Res. 42, 14-19.
50. Metzger, T.G., and Ferguson, D.M. (1995). On the role of extracellular loops of opioid receptors in conferring ligand selectivity. FEBS Lett. 375, 1-4.
51. Misicka, A., Lipkowski, A.W., Slaninova, J., Davis, P., Yamamura, H.I., Porecca, R, and Hruby, V.J. (1995). The synthesis and opioid receptor binding affinities of analogues of dermorphin and its N-terminal tetrapeptide fragment with dibasic acids in position 2. Life Sci. 57, 1633-1640.
52. Mosberg, H.I., Hurst, R., Hruby, V.J., Gee, K., Yamamura, H.I., Galligan, J.J., and Burks, T.F. (1983). Bis-penicillamine enkephalins possess highly improved specificity toward δ opioid receptors. Proc. Natl. Acad. Sci. USA. 80, 5871-5874.
53. Mosberg, H.I., Omnass, J.R., Sobczyk-Kojiro, K., Dua, R., Ho, J.C., Ma, W., Bush, P., Mousigian, C., and Lomize, A. (1994). Pharmacophore elements of the TIPP class of delta opioid receptor antagonists. Lett. Pept. Sci. 1, 69-72.
54. Nutt, R.F., Hally, F.W., Homick, C., Hirshman, R., and Veber, D.F. (1981). Synthesis of thyrotropin releasing hormone analogues with selective central nervous system effects. J. Med. Chem 24, 692-698.
55. Panzanelli, P., Valli, P., Cantino, D., and Fasolo, A. (1994). Glutamate and carnosine in the vestibular system of the frog. Brain Res. 662, 293-296.
56. Pitzele, B.S., Hamilton, R.W., Kudla, K.D., Tsymbalov, S., Stapelfeld, A., Savage, M.A., Clare, M., Hammond, D.L., and Hansen, D.W., Jr. (1994). Enkephalin analogs as systemically active antinociceptive agents: O-and N-alkylated derivatives of the dipeptide amide L-2,6-dimethyltyrosyl-N-(3-phenylpropyl)-D-alaninamide. J. Med. Chem. 37, 888-896.
57. Pognetto, M.S., Panzanelli, R, Fasolo, A., and Cantino, D. (1992). Expression of carnosine-like immunoreactivity during retinal development in the clawed frog (Xenopus laevis). Develop. Brain Res. 70, 134-138.
58. Porthogese, P.S., Nagase, H., MaloneyHuss, K.E., Lin, C.-E., and Takemori, A.E. (1991). Role of spacer and address components in peptidomimetic δ opioid receptor antagonists related to naltrindole. J. Med. Chem. 34, 1715-1720.
59. Prasad, C., and Peterkofsky, A. (1976). Demonstration of pyroglutamylpeptidase and amides activities toward thyrotropin-releasing hormone in hamster hypothalamus extracts. J. Biol. Chem. 251, 3229-3234.
60. Prasad, C., Edwards, R.M., Pegues, J., Mori, M., Wilber, J.F., Thomas, R.A., and Pierson, W. (1984). Distribution and characterization of cyclo (His-Pro)-like immunoreactivity in anuran (frog) skins. Peptides 5, 133-136.
61. Rónai, A.Z., Botyánski, J., Magyar, A., Borsodi, A., Benyhe, S., and Medzihradszky, K. (1993). Novel, δ-opioid receptor-selective peptide antagonists: demonstration of a possible opioid interaction in the absence of a protonated nitrogen and attempts to locate the protonated nitrogen site. Arch. Int. Pharmacodyn. 323, 114-125.
62. 1 analogues. Arch. Int. Pharcodyn. 330, 361-369.
63. Roseghini, M., Falconieri Erspamer, G., and Severini, C. (1988). Biogenic amines and active peptides in the skin of fifty-two African amphibian species other than bufonids. Comp. Biochem. Physiol. 91C, 281-286.
64. Sakurada, S., Sakurada, T., Jin, H., Sato, T., Kisara, K., Sasaki, Y., and Suzuki, K. (1982). Antinociceptive activities of synthetic dipeptides in mice. J. Pharm. Pharmacol. 34, 750-751.
65. Salvadori, S., Bianchi, C., Lazarus, L.H., Scaranari, V., Attila, M., and Tomatis, R. (1992). Para-substituted Phe3 deltorphin analogues: enhanced selectivity of halogenated derivatives for δ opioid receptor sites. J. Med. Chem. 35, 4651-4657.
66. 3-Substituted analogues of deltorphin C. Spatial conformation and topography of the aromatic ring in peptide recognition by δ opioid receptors. J. Med. Chem. 36, 3748-3756.
67. Salvadori, S., Attila, M., Balboni, G., Bianchi, C., Bryant, S.D., Crescenzi, O., Guerrini, R., Picone, D., Tancredi, T., Temussi, P.A., and Lazarus, L.H. (1995). δ Opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides. Molecular Med. 1, 678-689.
68. Sartania, N., Benyhe, S., Magyar, A., Rónai, A.Z., Medzihradszky, K., and Borsodi, A. (1996). Opioid binding profile of morphiceptin, Tyr-MIF-1 and dynorphin-related peptides in rat brain membranes. Neuropeptides 30, 225-230.
69. 2]deltorphin I analogs with extraordinary delta receptor activity. In: New Leads in Opioid Research, Vol. 914, J.M. van Ree, A.H. Mulder, V.M. Wiegant, and T.B. van Wimersma Greidanus, ed. (Amsterdam, The Netherlands: Excerpta Medica), pp. 288-290.
70. Schiller, P.W., Weltrowska, G., Nguyen, T.M.-D., Lemieux, C., Chung, N.N., Marsden, B.J., and Wilkes, B.C. (1991). Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects of receptor selectivity and stereospecificity. J. Med. Chem. 34, 3125-3132.
71. Schiller, P.W., Nguyen, T.M.-D., Weltrowska, G., Wilkes, B.C., Marsden, B.J., Lemieux, C., and Chung, N.N. (1992a). Differential stereochemical requirements of μ vs. δ opioid receptors for ligand binding and signal transduction: development of a class of potent and highly δ-selective peptide antagonists. Proc. Natl. Acad. Sci. 89, 11871-11875.
72. Schiller, P.W., Weltrowska, G., Nguyen, T.M.-D., Wilkes, B.C., Chung, N.N., and Lemieux, C. (1992b). Conformationally restricted deltorphin analogues. J. Med. Chem. 35, 3956-3961.
73. Schiller, P.W., Weltrowska, G., Nguyen, T.M.-D., Wilkes, B.C., Chung, N.N., and Lemieux, C. (1993). TIPP[ψ]: a highly potent and stable pseudopeptide δ opioid receptor antagonist with extraordinary δ selectivity. J. Med. Chem. 36, 3182-3187.
74. Shukla, R., Rahmani, N.H., Mizuma, H., Srimal, R.C., and Prasad, C. (1994). Role of endogenous cyclo(His-Pro) in cold-induced hypothermia in the desert rat (Mostomys natalensis). Peptides 15, 1471-1479.
75. Standifer, K.M., Chien, C.-C., Wahlestedt, C., Brown, G.P., and Pasternak, G.W. (1994). Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor. Neuron 12, 805-815.
76. Sternini, C., Spann, M., Anton, B., Keith, D.E., Jr., Bunnett, N.W., von Zastrow, M., Evans, C., and Brecha, N.C. (1996). Agonist-selective endocytosis of μ opioid receptor by neurons in vivo. Proc Natl. Acad. Sci. USA 93, 9241-9246.
77. Takaoka, O., Yamagata, Y., and Inomata, K. (1991). Diketopiperazine-mediated peptide formation in aqueous solution. II. Catalytic effect of phosphate. Origins Life Evol. Biosphere 21, 113-118.
78. Tancredi, T., Salvadori, S., Amodeo, P., Picone, D., Lazarus, L.H., Bryant, S.D., Guerrini, R., Marzola, G., and Temussi, P.A. (1994). Conversion of enkephalin and dermorphin into δ-selective opioid antagonists by single-residue substitution. Eur. J. Biochem. 224, 241-247.
79. Tang, Y., Chen, K.-X., Jiang, H.-L., Wang, Z.-X., Ji, R.-Y., and Chi, Z.-Q. (1996). Molecular modeling of μ opioid receptor and its interaction with ohmefentanyl. Acta Pharmacologia Sinica 17, 156-160.
80. Temussi, P.A., Salvadori, S., Amodeo, P., Bianchi, C., Guerrini, R., Tomatis, R., Lazarus, L.H., Picone, D., and Tancredi, T. (1994). Selective opioid dipeptides. Biochem. Biophys. Res. Commun. 198, 933-939.
81. Valiquette, M., Vu, H.K., Yue, S.Y., Wahlestedt, C., and Walker, P. (1996). Involvement of Trp-284, Val-296, and Val-297 of the human δ-opioid receptor in binding of δ-selective ligands. J. Biol. Chem. 271, 18789-18796.
82. van der Greef, J., Tas, A.C., Nijssen, L.M., and Jetten, J. (1987). Identification and quantification of diketopiperazines by liquid chromatography-mass spectrometry, using a moving belt interface. J. Chromatog. 394, 77-88.
83. Vaughn, L.K., Wire, W.S., Davis, P., Shimohigashi, Y., Tóth, G., Knapp, R.J., Hruby, V.J., Burks, T.F., and Yamamura, H.I. (1990). Differentiation between rat brain and mouse vas deferens δ opioid receptors. Eur. J. Pharmacol. 177, 99-101.
84. Vavrek, R.J., Hsi, L.-H., York, E.J., Hall, M.E., and Stewart, J.M. (1981). Minimum structure opioids - dipeptide and tripeptide analogs of the enkephalins. Peptides 2, 303-308.
85. Wagner, F.W., Kapleau, B.R., and Shepherd, S.L. (1975). Amino acid composition and sequence of urinary peptides containing hydroxyproline. Biochem. Med. 13, 343-352.
86. Walter, R., Ritzmann, R.F., Bhargava, H.N., and Flexner, L.B. (1979). Prolyl-leucyl-glycinamide, cyclo(leucylglycine), and derivatives block development of physical dependence on morphine in mice. Proc. Natl. Acad. Sci. USA 76, 518-520.